首页 > 最新文献

JAMA surgery最新文献

英文 中文
Preoperative Social Support and Impact on Outcomes After Elective Surgery in Older Adults. 术前社会支持对老年人择期手术后预后的影响。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4195
Karlynn Holland,Patrycja Lis,Steven Medvedovsky,Claire Ferguson,Dewi Sihaloho,Panos Kougias,Sherene E Sharath
{"title":"Preoperative Social Support and Impact on Outcomes After Elective Surgery in Older Adults.","authors":"Karlynn Holland,Patrycja Lis,Steven Medvedovsky,Claire Ferguson,Dewi Sihaloho,Panos Kougias,Sherene E Sharath","doi":"10.1001/jamasurg.2025.4195","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4195","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"54 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Difficult Cholecystectomy. 困难的胆囊切除术。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4199
Vincenzo Villani, Lilian S Kao, Yuman Fong

Importance: Difficult cholecystectomies are associated with a higher risk of severe bilio-vascular injuries.

Observations: Obesity, cirrhosis, high American Society of Anesthesiologists score, previous abdominal operations, and presence of acute cholecystitis or common bile duct stones are associated with difficult cholecystectomies. On imaging, thickened gallbladder wall, pericholecystic fluid, and an impacted gallstone are associated with difficult cholecystectomies. In challenging operations, the use of imaging (intraoperative cholangiography, intraoperative ultrasound, near-infrared cholangiography) is recommended. If the critical view of the hepatocystic triangle cannot be safely achieved, bailout strategies, such as tube cholecystostomy, subtotal cholecystectomy, or an anterograde approach, should be considered. Conversion to open surgery should be considered for significant bleeding, cholecystoenteric fistula, Mirizzi syndrome, or malignancy. Seeking advice or assistance from another surgeon is recommended when conditions are challenging.

Conclusions and relevance: Knowledge of perioperative and intraoperative adjuncts and alternative surgical options aid surgeons in performing difficult cholecystectomies safely.

重要性:困难的胆囊切除术与严重胆管损伤的高风险相关。观察:肥胖、肝硬化、美国麻醉医师学会评分高、既往腹部手术、急性胆囊炎或胆总管结石存在与胆囊切除术困难相关。在影像学上,胆囊壁增厚、胆囊周围积液和嵌塞胆囊结石与胆囊切除术困难有关。在具有挑战性的手术中,建议使用成像(术中胆管造影、术中超声、近红外胆管造影)。如果不能安全地获得肝囊三角的关键视图,则应考虑救助策略,如胆囊管造口术、胆囊次全切除术或顺行入路。如果出现严重出血、胆囊肠瘘、Mirizzi综合征或恶性肿瘤,应考虑转开腹手术。当情况困难时,建议向其他外科医生寻求建议或帮助。结论和相关性:了解围术期和术中辅助手段以及其他手术选择有助于外科医生安全地进行困难的胆囊切除术。
{"title":"The Difficult Cholecystectomy.","authors":"Vincenzo Villani, Lilian S Kao, Yuman Fong","doi":"10.1001/jamasurg.2025.4199","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4199","url":null,"abstract":"<p><strong>Importance: </strong>Difficult cholecystectomies are associated with a higher risk of severe bilio-vascular injuries.</p><p><strong>Observations: </strong>Obesity, cirrhosis, high American Society of Anesthesiologists score, previous abdominal operations, and presence of acute cholecystitis or common bile duct stones are associated with difficult cholecystectomies. On imaging, thickened gallbladder wall, pericholecystic fluid, and an impacted gallstone are associated with difficult cholecystectomies. In challenging operations, the use of imaging (intraoperative cholangiography, intraoperative ultrasound, near-infrared cholangiography) is recommended. If the critical view of the hepatocystic triangle cannot be safely achieved, bailout strategies, such as tube cholecystostomy, subtotal cholecystectomy, or an anterograde approach, should be considered. Conversion to open surgery should be considered for significant bleeding, cholecystoenteric fistula, Mirizzi syndrome, or malignancy. Seeking advice or assistance from another surgeon is recommended when conditions are challenging.</p><p><strong>Conclusions and relevance: </strong>Knowledge of perioperative and intraoperative adjuncts and alternative surgical options aid surgeons in performing difficult cholecystectomies safely.</p>","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145292121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Albumin Infusion and Kidney Injury in Cardiac Surgery-Reply. 心脏手术中白蛋白输注与肾损伤的关系。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4210
Mayurathan Balachandran,Adrian Pakavakis,Yahya Shehabi
{"title":"Albumin Infusion and Kidney Injury in Cardiac Surgery-Reply.","authors":"Mayurathan Balachandran,Adrian Pakavakis,Yahya Shehabi","doi":"10.1001/jamasurg.2025.4210","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4210","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"20 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Albumin Infusion and Kidney Injury in Cardiac Surgery. 心脏手术中白蛋白输注与肾损伤。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4207
Raffaele Saro,Daniele Orso,Tiziana Bove
{"title":"Albumin Infusion and Kidney Injury in Cardiac Surgery.","authors":"Raffaele Saro,Daniele Orso,Tiziana Bove","doi":"10.1001/jamasurg.2025.4207","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4207","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"91 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery at High-Quality Hospitals Among Medicare Advantage Beneficiaries Undergoing Cancer Surgery. 接受癌症手术的医疗保险优势受益人在高质量医院的手术。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4320
Avinash Maganty,Xiu Liu,Christopher Dall,Preeti Chachlani,Sarah Leick,Arnav Srivastava,Samuel R Kaufman,Vahakn B Shahinian,Brent K Hollenbeck
ImportanceEnrollment in Medicare Advantage (MA) accounts for more than half of Medicare beneficiaries. Despite this growth, its impact on access to high-quality cancer surgery remains unclear.ObjectiveTo evaluate the association between MA enrollment and receipt of surgery at high-quality hospitals among Medicare beneficiaries undergoing major cancer surgery.Design, Setting, and ParticipantsThis national retrospective cohort study uses Medicare Provider Analysis and Review (MedPAR) data from January 1, 2016, to November 30, 2022. The study included 567 770 Medicare beneficiaries undergoing elective surgery for esophageal, pancreatic, liver, gastric, bladder, colon, kidney, or prostate cancer at hospitals across the United States. Data analysis was performed from August 2024 to July 2025.ExposureEnrollment in Medicare Advantage plan.Main Outcomes and MeasuresThe primary outcome was surgery at a high-quality hospital, defined by procedure-specific mortality, risk-adjusted for patient characteristics and reliability-adjusted for differences in case volume using mixed-effects logistic regression models. Adjusted hospital mortality was rank ordered and sorted into quintiles. High quality was defined as hospitals in the quintile with the lowest mortality rates. The secondary outcome was likelihood of bypassing the nearest hospital of lower quality to undergo surgery at a high-quality hospital.ResultsAmong 567 770 beneficiaries undergoing surgery, 351 447 were enrolled in traditional Medicare (TM; 231 104 [65.8%] male, 120 343 [34.2%] female; mean [SD] age, 72.5 [8.0] years) and 216 323 in MA (138 554 [64.0%] male, 77 769 [36.0%] female; mean [SD] age, 72.7 [7.6] years). MA enrollment increased from 32% in 2016 to 46% in 2022. Compared with beneficiaries in TM, MA enrollees were more likely to be from socially vulnerable areas, have more comorbidities, and undergo surgery at nonteaching hospitals across all cancer types. Compared with those in TM, MA beneficiaries were less likely to undergo surgery at a high-quality hospital. For example, 21.7% (95% CI, 20.7%-22.8%) of patients enrolled in TA had an esophagectomy at a high-quality hospital vs 17.3% (95% CI, 16.1%-18.5%) of MA beneficiaries, and 22.6% (95% CI, 22.1%-23.2%) of patients enrolled in TA had a pancreatectomy at a high-quality hospital vs 16.2% (95% CI, 15.6%-16.8%) of those in MA. TM beneficiaries were more likely to bypass a lower-quality hospital to receive surgery at a high-quality hospital for all procedures.Conclusions and RelevanceThis study found that MA enrollees were less likely to receive cancer surgery at high-quality hospitals and less likely to bypass lower-quality hospitals. These findings suggest that current MA plan networks may limit access to optimal surgical care, raising concerns about the adequacy of cancer care delivery under privatized Medicare.
医疗保险优势(MA)的注册占医疗保险受益人的一半以上。尽管这种增长,但它对获得高质量癌症手术的影响尚不清楚。目的评价在接受重大癌症手术的医疗保险受益人中,MA入组与在高质量医院接受手术的关系。设计、环境和参与者本全国性回顾性队列研究使用了2016年1月1日至2022年11月30日的医疗保险提供者分析和评价(MedPAR)数据。该研究包括567 770名医疗保险受益人,他们在美国各地的医院接受食管癌、胰腺癌、肝癌、胃癌、膀胱癌、结肠癌、肾癌或前列腺癌的选择性手术。数据分析时间为2024年8月至2025年7月。参与医疗保险优势计划。主要结局和措施主要结局是在高质量的医院进行手术,由手术特定死亡率定义,根据患者特征进行风险调整,使用混合效应logistic回归模型根据病例量差异进行可靠性调整。调整后的医院死亡率按等级排序并按五分位数分类。高质量医院被定义为死亡率最低的五分之一医院。次要结局是绕过最近的低质量医院到高质量医院接受手术的可能性。结果567 770例手术受益人中,351 447例参加传统医疗保险(TM); 231 104例(65.8%)男性,120 343例(34.2%)女性,平均[SD]年龄72.5[8.0]岁);216 323例(138 554例(64.0%)男性,77 769例(36.0%)女性,平均[SD]年龄72.7[7.6]岁)。硕士入学率从2016年的32%增加到2022年的46%。与TM的受益人相比,MA的参与者更有可能来自社会脆弱地区,有更多的合并症,并且在所有癌症类型的非教学医院接受手术。与TM患者相比,MA患者较少在高质量医院接受手术。例如,21.7% (95% CI, 20.7%-22.8%)的TA组患者在高质量医院行食管切除术,而17.3% (95% CI, 16.1%-18.5%)的MA受益人行食管切除术,22.6% (95% CI, 22.1%-23.2%)的TA组患者在高质量医院行胰腺切除术,而16.2% (95% CI, 15.6%-16.8%)的MA组患者行胰腺切除术。TM受益人更有可能绕过低质量的医院,在高质量的医院接受所有手术。结论和相关性本研究发现,MA参选者在高质量医院接受癌症手术的可能性较小,绕过低质量医院的可能性较小。这些发现表明,目前的MA计划网络可能会限制获得最佳手术护理的机会,引起人们对私有化医疗保险下癌症护理提供的充分性的担忧。
{"title":"Surgery at High-Quality Hospitals Among Medicare Advantage Beneficiaries Undergoing Cancer Surgery.","authors":"Avinash Maganty,Xiu Liu,Christopher Dall,Preeti Chachlani,Sarah Leick,Arnav Srivastava,Samuel R Kaufman,Vahakn B Shahinian,Brent K Hollenbeck","doi":"10.1001/jamasurg.2025.4320","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4320","url":null,"abstract":"ImportanceEnrollment in Medicare Advantage (MA) accounts for more than half of Medicare beneficiaries. Despite this growth, its impact on access to high-quality cancer surgery remains unclear.ObjectiveTo evaluate the association between MA enrollment and receipt of surgery at high-quality hospitals among Medicare beneficiaries undergoing major cancer surgery.Design, Setting, and ParticipantsThis national retrospective cohort study uses Medicare Provider Analysis and Review (MedPAR) data from January 1, 2016, to November 30, 2022. The study included 567 770 Medicare beneficiaries undergoing elective surgery for esophageal, pancreatic, liver, gastric, bladder, colon, kidney, or prostate cancer at hospitals across the United States. Data analysis was performed from August 2024 to July 2025.ExposureEnrollment in Medicare Advantage plan.Main Outcomes and MeasuresThe primary outcome was surgery at a high-quality hospital, defined by procedure-specific mortality, risk-adjusted for patient characteristics and reliability-adjusted for differences in case volume using mixed-effects logistic regression models. Adjusted hospital mortality was rank ordered and sorted into quintiles. High quality was defined as hospitals in the quintile with the lowest mortality rates. The secondary outcome was likelihood of bypassing the nearest hospital of lower quality to undergo surgery at a high-quality hospital.ResultsAmong 567 770 beneficiaries undergoing surgery, 351 447 were enrolled in traditional Medicare (TM; 231 104 [65.8%] male, 120 343 [34.2%] female; mean [SD] age, 72.5 [8.0] years) and 216 323 in MA (138 554 [64.0%] male, 77 769 [36.0%] female; mean [SD] age, 72.7 [7.6] years). MA enrollment increased from 32% in 2016 to 46% in 2022. Compared with beneficiaries in TM, MA enrollees were more likely to be from socially vulnerable areas, have more comorbidities, and undergo surgery at nonteaching hospitals across all cancer types. Compared with those in TM, MA beneficiaries were less likely to undergo surgery at a high-quality hospital. For example, 21.7% (95% CI, 20.7%-22.8%) of patients enrolled in TA had an esophagectomy at a high-quality hospital vs 17.3% (95% CI, 16.1%-18.5%) of MA beneficiaries, and 22.6% (95% CI, 22.1%-23.2%) of patients enrolled in TA had a pancreatectomy at a high-quality hospital vs 16.2% (95% CI, 15.6%-16.8%) of those in MA. TM beneficiaries were more likely to bypass a lower-quality hospital to receive surgery at a high-quality hospital for all procedures.Conclusions and RelevanceThis study found that MA enrollees were less likely to receive cancer surgery at high-quality hospitals and less likely to bypass lower-quality hospitals. These findings suggest that current MA plan networks may limit access to optimal surgical care, raising concerns about the adequacy of cancer care delivery under privatized Medicare.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"1 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Albumin Infusion and Kidney Injury in Cardiac Surgery. 心脏手术中白蛋白输注与肾损伤。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4204
William Beaubien-Souligny,Jean Deschamps,André Denault
{"title":"Albumin Infusion and Kidney Injury in Cardiac Surgery.","authors":"William Beaubien-Souligny,Jean Deschamps,André Denault","doi":"10.1001/jamasurg.2025.4204","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4204","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"27 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reevaluating Mesh Weight in Inguinal Hernia Repair-Is the Weight Finally Over? 腹股沟疝修补补片重量的重新评估——补片重量是否已经结束?
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4318
Megan Melland-Smith,Michael Rosen
{"title":"Reevaluating Mesh Weight in Inguinal Hernia Repair-Is the Weight Finally Over?","authors":"Megan Melland-Smith,Michael Rosen","doi":"10.1001/jamasurg.2025.4318","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4318","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"1 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Transparency-FDA Guidance on Hernia Mesh Labeling. 提高透明度——fda关于疝补片标签的指导。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4192
Ahmad M Hider,Ryan Howard
{"title":"Improving Transparency-FDA Guidance on Hernia Mesh Labeling.","authors":"Ahmad M Hider,Ryan Howard","doi":"10.1001/jamasurg.2025.4192","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4192","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"1 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesh Weight in Reoperation for Recurrence After Laparoscopic Inguinal Hernia Repair. 补片重量在腹腔镜腹股沟疝修补术后复发再手术中的作用。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-15 DOI: 10.1001/jamasurg.2025.4328
Can Deniz Deveci,Jason Joe Baker,Jacob Rosenberg
ImportancePrevious studies on mesh weights have focused on the definitions of lightweight and heavyweight meshes, which were not based on clinical outcomes.ObjectiveTo investigate which mesh weight would be associated with the lowest reoperation rate for recurrence in laparoscopic inguinal hernia repair.Design, Setting, and ParticipantsThis nationwide cohort study was based on prospectively collected data on eligible patients aged 18 years or older who had undergone a primary transabdominal preperitoneal laparoscopic inguinal hernia repair in Denmark between January 1998 and July 2023 from the Danish Inguinal Hernia Database, obtained through population-based sampling. The final grouping included patients who received a mesh with a weight of <45 g/m2, 45-65 g/m2, or >65 g/m2. The database linkage to the Danish National Patient Registry made it possible to follow-up patients until the date of data extraction, death, emigration, or reoperation. Sequential explorative analyses were conducted to compare all mesh weight intervals to find the weight interval that resulted in the lowest risk of reoperation for recurrence.Main Outcomes and MeasuresThe main outcome was reoperation for recurrence using a Cox proportional hazards regression model.ResultsA total of 43 986 inguinal hernias from 36 446 patients were included: 16 949 in the less than 45-g/m2 group, 16 531 in the 45- to 65-g/m2 group, and 10 506 in the greater than 65-g/m2 group. A total of 1910 (4.34%) inguinal hernias underwent reoperation for recurrence. The mesh weight interval of 45 to 65 g/m2 had the lowest risk of reoperation for recurrence. Compared with a mesh weight of 45 to 65 g/m2, a mesh weight of less than 45 g/m2 had a hazard ratio for reoperation of 2.6 (95% CI, 2.2-2.8; P < .001), and a mesh weight of greater than 65 g/m2 had a hazard ratio of 2.4 (95% CI, 2.1-2.8; P < .001) for reoperation.Conclusions and RelevanceThis nationwide cohort study found that a mesh weight of 45 to 60 g/m2 resulted in the lowest risk of reoperation for recurrence compared with other mesh weights in laparoscopic inguinal hernia repair. These findings suggest that selecting a mesh within 45 to 60 g/m2 can optimize outcomes and reduce the need for reoperation.
先前关于网片重量的研究主要集中在轻量级和重量级网片的定义上,而不是基于临床结果。目的探讨腹腔镜腹股沟疝修补术中补片重量与再手术复发率的关系。设计、环境和参与者本全国性队列研究基于前瞻性收集的数据,这些数据来自1998年1月至2023年7月期间在丹麦接受过经腹膜前腹腔镜腹股沟疝修补术的18岁或以上的患者,这些患者来自丹麦腹股沟疝数据库,通过基于人群的抽样获得。最后一组包括接受重量为65 g/m2的补片的患者。与丹麦国家患者登记处的数据库链接使得对患者进行随访成为可能,直到数据提取、死亡、移民或再手术的日期。序贯探索性分析比较所有网格权重区间,以找到导致复发再手术风险最低的权重区间。主要结局和指标采用Cox比例风险回归模型,主要结局为复发再手术。结果36 446例患者共纳入43 986例腹股沟疝:小于45 g/m2组16 949例,45 ~ 65 g/m2组16 531例,大于65 g/m2组10 506例。共有1910例(4.34%)腹股沟疝因复发而再次手术。补片重量间隔为45 ~ 65 g/m2时,再手术复发的风险最低。与目重45 ~ 65 g/m2相比,目重小于45 g/m2的再手术风险比为2.6 (95% CI, 2.2 ~ 2.8; P <。大于65 g/m2的网重的风险比为2.4 (95% CI, 2.1-2.8; P < 0.05)。001)以便重新操作。结论和相关性这项全国性队列研究发现,腹腔镜腹股沟疝修补术中,与其他补片重量相比,补片重量为45 - 60 g/m2的补片复发再手术风险最低。这些研究结果表明,选择45至60 g/m2的补片可以优化结果并减少再次手术的需要。
{"title":"Mesh Weight in Reoperation for Recurrence After Laparoscopic Inguinal Hernia Repair.","authors":"Can Deniz Deveci,Jason Joe Baker,Jacob Rosenberg","doi":"10.1001/jamasurg.2025.4328","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4328","url":null,"abstract":"ImportancePrevious studies on mesh weights have focused on the definitions of lightweight and heavyweight meshes, which were not based on clinical outcomes.ObjectiveTo investigate which mesh weight would be associated with the lowest reoperation rate for recurrence in laparoscopic inguinal hernia repair.Design, Setting, and ParticipantsThis nationwide cohort study was based on prospectively collected data on eligible patients aged 18 years or older who had undergone a primary transabdominal preperitoneal laparoscopic inguinal hernia repair in Denmark between January 1998 and July 2023 from the Danish Inguinal Hernia Database, obtained through population-based sampling. The final grouping included patients who received a mesh with a weight of <45 g/m2, 45-65 g/m2, or >65 g/m2. The database linkage to the Danish National Patient Registry made it possible to follow-up patients until the date of data extraction, death, emigration, or reoperation. Sequential explorative analyses were conducted to compare all mesh weight intervals to find the weight interval that resulted in the lowest risk of reoperation for recurrence.Main Outcomes and MeasuresThe main outcome was reoperation for recurrence using a Cox proportional hazards regression model.ResultsA total of 43 986 inguinal hernias from 36 446 patients were included: 16 949 in the less than 45-g/m2 group, 16 531 in the 45- to 65-g/m2 group, and 10 506 in the greater than 65-g/m2 group. A total of 1910 (4.34%) inguinal hernias underwent reoperation for recurrence. The mesh weight interval of 45 to 65 g/m2 had the lowest risk of reoperation for recurrence. Compared with a mesh weight of 45 to 65 g/m2, a mesh weight of less than 45 g/m2 had a hazard ratio for reoperation of 2.6 (95% CI, 2.2-2.8; P < .001), and a mesh weight of greater than 65 g/m2 had a hazard ratio of 2.4 (95% CI, 2.1-2.8; P < .001) for reoperation.Conclusions and RelevanceThis nationwide cohort study found that a mesh weight of 45 to 60 g/m2 resulted in the lowest risk of reoperation for recurrence compared with other mesh weights in laparoscopic inguinal hernia repair. These findings suggest that selecting a mesh within 45 to 60 g/m2 can optimize outcomes and reduce the need for reoperation.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"78 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145288432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing Missed Doses of VTE Prophylaxis. 减少静脉血栓栓塞预防遗漏剂量。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2025-10-08 DOI: 10.1001/jamasurg.2025.4142
John T Simpson,Krista L Haines,Suresh Agarwal
{"title":"Reducing Missed Doses of VTE Prophylaxis.","authors":"John T Simpson,Krista L Haines,Suresh Agarwal","doi":"10.1001/jamasurg.2025.4142","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.4142","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"9 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145246429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1